Heck Capital Advisors’s DexCom DXCM Stock Holding History

Heck Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-490	Closed	-$38.1K	–	404
2024 Q4	$38.1K	Buy	+490	New	+$36.3K	﹤0.01%	406

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Heck Capital Advisors's DXCM Position: Q1 2025 in Review

Heck Capital Advisors sold out of DexCom (DXCM) in Q1 2025, closing a stake of 490 shares — an estimated $38.1K sold.

Heck Capital Advisors first reported a position in DXCM in Q4 2024 and held it in 1 quarter. The position peaked at $38.1K in Q4 2024. 933 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

Heck Capital Advisors reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
Heck Capital Advisors sold 490 DexCom shares in Q1 2025, an estimated $38.1K.
Heck Capital Advisors first reported a position in DexCom in Q4 2024 and held it in 1 quarter.
Heck Capital Advisors's DexCom position peaked at $38.1K in Q4 2024.
933 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Heck Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.